J. Safra Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$14.4M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$6.83M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$4.3M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$4.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$72.5M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$17.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$11.8M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$6.42M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$3.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 0.79% |
| 2 | Energy | 0.5% |
| 3 | Financials | 0.24% |
| 4 | Technology | 0.15% |
| 5 | Communication Services | 0.05% |
Similar funds
J. Safra Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, J. Safra Asset Management held 152 positions worth $5.86M, up 9% from $5.37M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
J. Safra Asset Management withdrew a net $71.5M in Q2 2022, closing 82 positions and reducing 48 holdings. Its most notable exit was Sorrento Therapeutics, Inc., an estimated $5K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 0.79% of assets, up from 0.19% a quarter earlier, followed by Energy and Financials.
Against the trend, J. Safra Asset Management opened a new position in State Street SPDR S&P Biotech ETF worth $445K.
- J. Safra Asset Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 33,068 shares worth $445K.
- J. Safra Asset Management added most to iShares Russell 1000 Growth ETF in Q2 2022, an estimated $14.6M increase.
- J. Safra Asset Management's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $72.5M.
- J. Safra Asset Management fully exited Sorrento Therapeutics, Inc. in Q2 2022, selling an estimated $5K.
- J. Safra Asset Management's ten largest holdings make up 94% of its $5.86M portfolio in Q2 2022.
- J. Safra Asset Management opened 8 new positions and closed 82 in Q2 2022.
- J. Safra Asset Management's portfolio value rose 9% quarter-over-quarter to $5.86M.
Based on J. Safra Asset Management's 13F filing for Q2 2022, filed 1 Aug 2022.